Chinese 
English 
鑑於在所屬生物科技領域的非凡影響力以及作出的傑出貢獻，香港微科行政總裁 James Chan 獲邀出席參加於中國北京舉行的 “同根同夢 • 2025 全球華人春節聯歡晚會”，並出席楷模人物年度盛典。
香港微科生物技術有限公司是一家專營生物高科技試劑產品及科學儀器的分銷商， 成立於2018 年，總部位於香港， 是世界知名生物企業日本 ZENOAQ、日本 MATRIXOME, INC 等品牌的香港區獨家代理商。公司亦於2024年榮獲 MythFocus 頒發「亞洲最有價值品牌大獎 2024」中的 「年度最具信譽生物科技方案」大獎；並於2023年榮獲 Hong Kong Economic Times (HKCT) 頒發「年度最傑出生物技術產品」獎項。
Other news
同根同夢 · 2025 全球華人春節聯歡晚會暨楷模人物年度盛典
In view of extraordinary influence in the biotechnological industry, our CEO, James Chan was sincerely
1 月
亞洲最有價值品牌大獎2024
Hong Kong Weike Biotechnology Company Limited was awarded “Most Trusted Biotechnology Solutions Of The Year” of Asia’s
9 月
Scientific Annual Report of CELLBANKERs (2023)
・ The number of citations in 2023 was 266 and reached record high. ・The number of
5 月
2023年度最傑出生物技術產品
Hong Kong Weike Biotechnology Company Limited was awarded「年度最傑出生物技術產品」of the HKCT Business Awards 2023 held by
9 月
Global Cell Freezing Media for Cell Therapy Professional Survey Report
A report titled, “Global Cell Freezing Media for Cell Therapy Professional Survey Report 2022, Forecast
4 月
CELLBANKER’s Scientific Annual Report (2021)
ZENOAQ has issued publications on research of cell cryopreserved regularly. Here is the summary for
2 月